Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bio-Path Holdings, Inc. - Common Stock (NQ:BPTH)

0.2100 UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.2100
Bid (Size) 0.2001 (50)
Ask (Size) 0.2142 (42)
Prev. Close 0.2100
Today's Range 0.2100 - 0.2100
52wk Range 0.2100 - 3.390
Shares Outstanding 5,768,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Life Sciences Investor Forum: Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum
From Bio-Path Holdings, Inc.
Via GlobeNewswire

Performance

YTD
-81.7%
-81.7%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
-77.9%
-77.9%
1 Year
-88.8%
-88.8%

More News

Read More
Life Sciences Investor Forum Agenda Announced for June 11th-12th
From Virtual Investor Conferences
Via GlobeNewswire
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 25
Via Newsfile
Topics Intellectual Property
Bio-Path Holdings Provides Clinical and Operational Update
From Bio-Path Holdings, Inc.
Via GlobeNewswire
Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025
From Bio-Path Holdings, Inc.
Via GlobeNewswire
Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
From Bio-Path Holdings, Inc.
Via GlobeNewswire
Bio-Path Holdings Reports Full Year 2024 Financial Results
From Bio-Path Holdings, Inc.
Via GlobeNewswire
Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
From Bio-Path Holdings, Inc.
Via GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Via Chartmill
Which stocks are moving on Tuesday?
Via Chartmill
Tuesday's session: gap up and gap down stocks
Via Chartmill
US Stocks Mixed; NY State Business Activity Rises In February
Via Benzinga
Wondering what's happening in today's pre-market session?
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Bio-Path Holdings Expands Global Patent Portfolio
From Bio-Path Holdings, Inc.
Via GlobeNewswire
Bio-Path Holdings Provides Key Clinical Updates
From Bio-Path Holdings, Inc.
Via GlobeNewswire
Wondering what's happening in today's after-hours session?
Via Chartmill
Bio-Path Holdings Provides Update from Phase 1/1b Clinical Trial of BP1002 for Treatment of Refractory/Relapsed Acute Myeloid Leukemia
From Bio-Path Holdings, Inc.
Via GlobeNewswire
Bio-Path Holdings Provides 2025 Clinical and Operational Update
From Bio-Path Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Nasdaq Jumps 100 Points, US Initial Jobless Claims Decline
Via Benzinga
Bio-Path Holdings Shares Were On The Rise: What's Going On?
Via Benzinga
Gold Falls Sharply, Lamb Weston Shares Plunge
Via Benzinga
US Stocks Higher, Micron Reports Downbeat Sales
Via Benzinga

Frequently Asked Questions

Is Bio-Path Holdings, Inc. - Common Stock publicly traded?
Yes, Bio-Path Holdings, Inc. - Common Stock is publicly traded.
What exchange does Bio-Path Holdings, Inc. - Common Stock trade on?
Bio-Path Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Bio-Path Holdings, Inc. - Common Stock?
The ticker symbol for Bio-Path Holdings, Inc. - Common Stock is BPTH on the Nasdaq Stock Market
What is the current price of Bio-Path Holdings, Inc. - Common Stock?
The current price of Bio-Path Holdings, Inc. - Common Stock is 0.2100
When was Bio-Path Holdings, Inc. - Common Stock last traded?
The last trade of Bio-Path Holdings, Inc. - Common Stock was at 02/18/25 04:00 PM ET
What is the market capitalization of Bio-Path Holdings, Inc. - Common Stock?
The market capitalization of Bio-Path Holdings, Inc. - Common Stock is 1.21M
How many shares of Bio-Path Holdings, Inc. - Common Stock are outstanding?
Bio-Path Holdings, Inc. - Common Stock has 1M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.